Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Tew

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Current Opinion in Pharmacology|October 14, 2009
Redox pathways in cancer drug discoveryKenneth D Tew
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Is there a role for glyoxalase I inhibitors as antitumor drugs?Kenneth D. Tew
Pigment Cell & Melanoma Research|January 5, 2012
NrF2 ⁄Keap1 as gatekeepers of redox homeostasis – do they prevent or cause cancer?Kenneth D Tew
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2015
Editor's NoteKenneth D Tew
Molecular Cancer Therapeutics|March 18, 2004
Small molecule inhibition of hypoxia inducible factor-1alpha: a viable therapeutic approach?Kenneth D Tew
Cancer Research|September 3, 2016
Commentary on "Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents"Kenneth D Tew
Biochemical Pharmacology|November 14, 2006
Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylationKenneth D Tew
Biochemical Pharmacology|December 14, 2011
Drug resistance in cancer. EditorialKenneth D Tew
Cancer Research|January 6, 2016
Glutathione-Associated Enzymes In Anticancer Drug ResistanceKenneth D Tew
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 19, 2006
How is a conservative US administration influencing NCI funding?Kenneth D Tew
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Current Opinion in Pharmacology|October 14, 2009
Redox pathways in cancer drug discoveryKenneth D Tew
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Is there a role for glyoxalase I inhibitors as antitumor drugs?Kenneth D. Tew
Pigment Cell & Melanoma Research|January 5, 2012
NrF2 ⁄Keap1 as gatekeepers of redox homeostasis – do they prevent or cause cancer?Kenneth D Tew
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2015
Editor's NoteKenneth D Tew
Molecular Cancer Therapeutics|March 18, 2004
Small molecule inhibition of hypoxia inducible factor-1alpha: a viable therapeutic approach?Kenneth D Tew
Cancer Research|September 3, 2016
Commentary on "Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents"Kenneth D Tew
Biochemical Pharmacology|November 14, 2006
Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylationKenneth D Tew
Biochemical Pharmacology|December 14, 2011
Drug resistance in cancer. EditorialKenneth D Tew
Cancer Research|January 6, 2016
Glutathione-Associated Enzymes In Anticancer Drug ResistanceKenneth D Tew
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 19, 2006
How is a conservative US administration influencing NCI funding?Kenneth D Tew
Pageof 12